Developing a library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related degradation.
Location: United States, California, San Francisco
Total raised: $27.5M
Investors 1
Date | Name | Website |
- | Mitsui Glo... | mitsui-glo... |
Funding Rounds 3
Date | Series | Amount | Investors | Deal News |
26.04.2019 | - | $11M | - | finsmes.co... |
27.08.2015 | Grant | $1.5M | - | finsmes.co... |
05.01.2015 | Series A | $15M | - | finsmes.co... |
Mentions in press and media 4
Date | Title | Description | Category | Author | Source |
26.04.2019 | Symic Bio ... | Symic Bio, a San Francisco, CA... | USA | - | finsmes.co... |
27.08.2015 | Daily fund... | Yuneec bagged $60M; MediBeacon... | - | Mitos Suso... | vator.tv/n... |
27.08.2015 | Symic Biom... | Symic Biomedical, Inc., a San ... | USA | - | finsmes.co... |
05.01.2015 | Symic Biom... | Symic Biomedical, a San Franci... | USA | - | finsmes.co... |